Three- and seven-day perfusion of dog kidney with human plasma protein fraction IV-4
Liu, W.P.; Humphries, A.L.; Russell, R.; Stoddard, L.D.; Garcia, L.A.; Serkes, K.D.
Surgical Forum 24: 316-318
1973
ISSN/ISBN: 0071-8041 PMID: 4806016 Document Number: 58012
Document emailed within 1 workday
Related Documents
Johnson, R.W.; Cohen, G.L.; Mallick, N.P.; Orr, W.M. 1979: Renal function and early cadaver graft survival after continuous hypothermic perfusion with plasma protein fraction (PPF) Transplantation Proceedings 11(2): 1476Berglöf, J.H.; Eriksson, S.; Andersson, I. 1987: New supports for plasma protein fraction: optimization and application of gel filtration using an improved sephacryl S-200 gel Developments in Biological Standardization 67: 25-29
Holohan, P.D.; Pessah, N.I.; Pessah, I.N.; Ross, C.R. 1979: Reconstitution of N1-methylnicotinamide and p-aminohippuric acid transport in phospholipid vesicles with a protein fraction isolated from dog kidney membranes Molecular Pharmacology 16(1): 343-356
Bakker, J.C.; de Vries-van Rossen, A.; Radema, H.; Bleeker, W.; Ufkes, J.G.; van Rosevelt, R.F.; van Mourik, J.A. 1983: Identification of a bradykinin-generating hypotensive substance in plasma protein fraction: prekallikrein activator (PKA-beta-Xiia) Advances in Experimental Medicine and Biology 156: 1091-1097
Kakhki, V.R.D.; Zakavi, S.R.; Sadeghi, R. 2007: Comparison of two software in gated myocardial perfusion single photon emission tomography, for the measurement of left ventricular volumes and ejection fraction, in patients with and without perfusion defects Hellenic Journal of Nuclear Medicine 10(1): 19-23
Occhino, J.C.; Glasgow, A.H.; Cooperband, S.R.; Mannick, J.A.; Schmid, K. 1973: Isolation of an immunosuppressive peptide fraction from human plasma Journal of Immunology 110(3): 685-694
Perrier, H.; Perrier, C.; Pérès, G.; Gras, J. 1979: Immediate effects of thermal shocks on the plasma level of various components in the Rainbow trout: compounds indicating stress and protein fraction Revue Canadienne de Biologie 38(1): 37-41
Uteg, K.H.; Tausenfreund, K.; Schössler, W. 1985: In vitro characterization of human plasma fraction factor VIIi concentrate Die Pharmazie 40(4): 270
Ho Ngoc-Ta Trung, A.; Sirois, G. 1987: Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios Pharmaceutica Acta Helvetiae 62(2): 61-64
Bednarík, T.; Cajthamlová, H. 1975: Suppression of antibody production in mice and rabbits upon administration of human plasma alpha globulin fraction Casopis Lekaru Ceskych 114(47): 1466-1468
Lostický, C.; Bednarík, T.; Cajthamlová, H. 1982: Chromatographic characterization of the low molecular weight immunosuppressive component of the alpha globulin fraction in human plasma Ceskoslovenska Farmacie 31(5): 171-173
Adler, G.; Eichman, W.; Szczepanski, M.; Targonska, I.; Jasinska, A. 1998: Postoperative plasma interleukin-6 in patients with renal cancer correlates with C-reactive protein but not with total fibrinogen or with high molecular weight fibrinogen fraction Thrombosis Research 89(5): 243-248
Tsuchida, A.; Thomson, N.M.; Salem, H.H.; Atkins, R.C.; Hancock, W.W. 1990: Serial monitoring shows plasma protein C and free protein S levels are decreased during human acute renal allograft rejection Transplantation Proceedings 22(5): 2134-2136
Vecchi, V.; Faldella, G.; Paolucci, G. 1977: Use of a human placental extract. Human placental S fraction or HRPS fraction in therapy of children with asthmatic bronchitis Minerva Pediatrica 29(20): 1323-1330
Bednaăík, T.; Cajthamlová, H. 1976: Suppression of humoral antibody formation in rabbits. Administration of alpha globulin fraction of human plasma and antilymphocytic globulin Casopis Lekaru Ceskych 115(48): 1490-1492
Khan, H.; Jan, S.U.; Hashmatullah; Khan, M.F.; Khan, K.A.; Rehman, A.U.; Wahab, A. 2010: Effect of lithium metal on the chemical status of glutathione (GSH) present in whole blood (especially in plasma and cytosolic fraction in human blood) Pakistan Journal of Pharmaceutical Sciences 23(2): 188-193
Zakiyanov, O.; Kalousov, M.á; Markéta Kratochvilová; Vítĕzslav Kříha; Tomáš Zima; Vladimír Tesař 2012: Determinants of Circulating Matrix Metalloproteinase-2 and Pregnancy-Associated Plasma Protein-A in Patients with Chronic Kidney Disease Clinical Laboratory 58(5-6): 471-480
Goldsmith, H.S.; Griffith, A.L.; Catsimpoolas, N. 1986: Increased vascular perfusion after administration of an omental lipid fraction Surgery Gynecology and Obstetrics 162(6): 579-583
Laurell, M.; Stenflo, J. 1989: Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein Thrombosis and Haemostasis 62(3): 885-891
Umemori, M.; Onda, M.; Tajiri, T.; Sasajima, K.; Takano, T. 1991: Plasma exchange and plasma perfusion applying arteriovenous pressure difference Nihon Rinsho. Japanese Journal of Clinical Medicine 49 Suppl: 618-624